FDA clears digital therapeutic for abdominal pain from IBS
MetaMe received FDA clearance for its first digital therapeutic on Tuesday. It uses behavioral therapy to help alleviate abdominal pain symptoms for patients with irritable bowel syndrome.
Oshi Health targets costly GI conditions with virtual care, raises $23M
Oshi Health raised $23 million in funding, with CVS Health and Takeda joining as strategic investors. The company has built a digital health platform to help people manage GI conditions, such as Crohn’s disease and IBS.
presented by
The Definitive Guide to Medical Billing Outsourcing: 5 Top Companies
In today’s healthcare landscape, your choice of medical billing partner directly impacts your bottom line. What are the best medical billing outsourcing companies, and which one is right for you?
MetaMe raises $3.8M to create a hypnosis-based DTX for your IBS
The company's lead product Regulora delivers a standardized 12-week therapy which bring patients into a state of deep relaxation and suggestibility before using metaphors and stories to create a sense of comfort and ease around the individual's condition and symptoms.